Ranexa and Ketoconazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranexa (ranolazine) and Ketoconazole (ketoconazole). Common drug interactions include renal impairment among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Ranexa and Ketoconazole. It is created by eHealthMe based on reports of 77 people who take the same drugs from the FDA, and is updated regularly.

What is Ranexa?

Ranexa has active ingredients of ranolazine. It is often used in angina. eHealthMe is studying from 11,758 Ranexa users. Check the latest studies of Ranexa.

What is Ketoconazole?

Ketoconazole has active ingredients of ketoconazole. It is often used in fungal infection. eHealthMe is studying from 16,014 Ketoconazole users. Check the latest studies of Ketoconazole.



On Jul, 17, 2026

77 people who take Ranexa and Ketoconazole together, and have interactions are studied.

Ranexa and Ketoconazole drug interactions.

What are the common drug interactions of Ranexa and Ketoconazole, by gender? *:

female:

  1. Renal impairment (severely reduced kidney function)
  2. Renal injury (kidney injury)
  3. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  4. Urinary tract infection
  5. Menopause (end of monthly cycles in women)
  6. Menstruation irregular
  7. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  8. Anaemia (lack of blood)
  9. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  10. Back pain

male:

  1. Chronic kidney disease
  2. Anxiety
  3. Cystitis (inflammation of the wall of the bladder)
  4. Dehydration (dryness resulting from the removal of water)
  5. Encephalopathy (functioning of the brain is affected by some agent or condition)
  6. Fall
  7. Hospitalisation
  8. Hot flush (sudden feelings of heat)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)

What are the common drug interactions of Ranexa and Ketoconazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Menopause (end of monthly cycles in women)
  2. Menstruation irregular
  3. Headache (pain in head)
  4. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  5. Vulvovaginal mycotic infection (vulvovaginal fungal infection)

50-59:

  1. Rib fracture
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  4. Bone density decreased
  5. Cardiac disorder
  6. Cataract (clouding of the lens inside the eye)
  7. Chronic kidney disease
  8. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  9. Death
  10. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Blood glucose decreased
  4. Fall
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Hot flush (sudden feelings of heat)
  7. Infection
  8. Stent placement
  9. Urinary tract infection
  10. Vomiting

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 18 people, 23.38%
  2. Hyperkalemia (damage to or disease of the kidney): 16 people, 20.78%
  3. High Blood Pressure: 14 people, 18.18%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 18.18%
  5. Cardiac Disorder: 13 people, 16.88%
  6. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 11 people, 14.29%
  7. Pain: 11 people, 14.29%
  8. Stable Angina (a constant chest pain): 11 people, 14.29%
  9. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 10 people, 12.99%
  10. High Blood Cholesterol: 10 people, 12.99%

* Approximation only. Some reports may have incomplete information.

Do you take Ranexa and Ketoconazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ranexa and Ketoconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ranexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ketoconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranexa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ketoconazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ranolazine and ketoconazole (the active ingredients of Ranexa and Ketoconazole, respectively), and Ranexa and Ketoconazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: